现代诊断与治疗
現代診斷與治療
현대진단여치료
MODERN DIAGNOSIS AND TREATMENT
2013年
13期
2892-2894
,共3页
胡茂荣%姜淑珍%占海燕%胡斌%鲍成%余斌%周朝雄%吴慧玲
鬍茂榮%薑淑珍%佔海燕%鬍斌%鮑成%餘斌%週朝雄%吳慧玲
호무영%강숙진%점해연%호빈%포성%여빈%주조웅%오혜령
首发精神分裂症%记忆功能%阿立哌唑%利培酮
首髮精神分裂癥%記憶功能%阿立哌唑%利培酮
수발정신분렬증%기억공능%아립고서%리배동
First-episode Schizophrenia%Memory Function%Aripiprazole%Risperidone
目的:探讨阿立哌唑和利培酮对首发精神分裂症患者记忆功能的影响。方法112例首发精神分裂症患者随机分成阿立哌唑组和利培酮组,每组56例。在治疗前和治疗12周末采用韦氏记忆量表-第三版的空间广度测验(WMS-Ⅲ SST)、霍普金斯词汇学习测验-修订版(HVLT-R)、简单视觉空间记忆测验-修订版(BVMT-R)分别对工作记忆、言语记忆和视觉记忆领域进行评定。结果在治疗前,两组的WMS-Ⅲ SST HVLT-R 和BVMT-R得分比较均无统计学意义(P>0.05)。在治疗12周后,两组的HVLT-R 和BVMT-R得分较治疗前比较均有统计学意义(P<0.05)而治疗后两组间比较无统计学意义(P>0.05);阿立哌唑组在治疗后的WMS-Ⅲ SST得分较治疗前显著增加(P<0.05),且治疗后两组间比较有统计学意义(P<0.05),而利培酮治疗前后WMS-Ⅲ SST得分比较无统计学意义(P>0.05)。结论阿立哌唑和利培酮对首发精神分裂症患者记忆功具有改善作用,阿立哌唑对某些记忆功能改善优于利培酮。
目的:探討阿立哌唑和利培酮對首髮精神分裂癥患者記憶功能的影響。方法112例首髮精神分裂癥患者隨機分成阿立哌唑組和利培酮組,每組56例。在治療前和治療12週末採用韋氏記憶量錶-第三版的空間廣度測驗(WMS-Ⅲ SST)、霍普金斯詞彙學習測驗-脩訂版(HVLT-R)、簡單視覺空間記憶測驗-脩訂版(BVMT-R)分彆對工作記憶、言語記憶和視覺記憶領域進行評定。結果在治療前,兩組的WMS-Ⅲ SST HVLT-R 和BVMT-R得分比較均無統計學意義(P>0.05)。在治療12週後,兩組的HVLT-R 和BVMT-R得分較治療前比較均有統計學意義(P<0.05)而治療後兩組間比較無統計學意義(P>0.05);阿立哌唑組在治療後的WMS-Ⅲ SST得分較治療前顯著增加(P<0.05),且治療後兩組間比較有統計學意義(P<0.05),而利培酮治療前後WMS-Ⅲ SST得分比較無統計學意義(P>0.05)。結論阿立哌唑和利培酮對首髮精神分裂癥患者記憶功具有改善作用,阿立哌唑對某些記憶功能改善優于利培酮。
목적:탐토아립고서화리배동대수발정신분렬증환자기억공능적영향。방법112례수발정신분렬증환자수궤분성아립고서조화리배동조,매조56례。재치료전화치료12주말채용위씨기억량표-제삼판적공간엄도측험(WMS-Ⅲ SST)、곽보금사사회학습측험-수정판(HVLT-R)、간단시각공간기억측험-수정판(BVMT-R)분별대공작기억、언어기억화시각기억영역진행평정。결과재치료전,량조적WMS-Ⅲ SST HVLT-R 화BVMT-R득분비교균무통계학의의(P>0.05)。재치료12주후,량조적HVLT-R 화BVMT-R득분교치료전비교균유통계학의의(P<0.05)이치료후량조간비교무통계학의의(P>0.05);아립고서조재치료후적WMS-Ⅲ SST득분교치료전현저증가(P<0.05),차치료후량조간비교유통계학의의(P<0.05),이리배동치료전후WMS-Ⅲ SST득분비교무통계학의의(P>0.05)。결론아립고서화리배동대수발정신분렬증환자기억공구유개선작용,아립고서대모사기억공능개선우우리배동。
Objective To explore the efficacy of aripiprazole and risperidone on memory function in patients with schizophrenia. Methods 112 first-episode patients with schizophrenia were random-ized to aripiprazole group(n=56) and risperidone group(n=56). All subjects were assessed with the Wechsler Memory Scale-ⅢSpatial Span Task(WMS-Ⅲ SST), the Hopkins Verbal Learning Test-Re-vised (HVLT-R) and The Brief Visuospatial Memory Test-Revised (BVMT-R).Results Both groups showed no statistical significance in WMS-Ⅲ SST, HVLT-R and BVMT-R scores in the baseline (P>0.05).The performances after 12 weeks of treatment in the both groups was higher than those in the baseline in all tests(P<0.05) except for the WMS-III SST in the risperidone group(P<0.05). After treatment, there was no significant difference between the two groups (P>0.05).Aripiprazole group was increased significantly compared with before treatment after treatment WMS-Ⅲ SST score (P<0.05), and after treatment there was a statistical significance between the two groups (P<0.05).Conclusion Memory impairments in the patients with first-episode schizophrenia was im-proved by aripiprazole and risperidone, and effect of aripiprazole on certain memory functions was better than those of risperidone.